| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |